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Abstract
Concept recognition tools rely on the availability of textual corpora to assess their per-
formance and enable the identification of areas for improvement. Typically, corpora are
developed for specific purposes, such as gene name recognition. Gene and protein
name identification are longstanding goals of biomedical text mining, and therefore a
number of different corpora exist. However, phenotypes only recently became an entity
of interest for specialized concept recognition systems, and hardly any annotated text is
available for performance testing and training. Here, we present a unique corpus, captur-
ing text spans from 228 abstracts manually annotated with Human Phenotype Ontology
(HPO) concepts and harmonized by three curators, which can be used as a reference
standard for free text annotation of human phenotypes. Furthermore, we developed a
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test suite for standardized concept recognition error analysis, incorporating 32 different
types of test cases corresponding to 2164 HPO concepts. Finally, three established
phenotype concept recognizers (NCBO Annotator, OBO Annotator and Bio-LarK CR)
were comprehensively evaluated, and results are reported against both the text
corpus and the test suites. The gold standard and test suites corpora are available from
http://bio-lark.org/hpo_res.html.
Database URL: http://bio-lark.org/hpo_res.html
Introduction
The Human Phenotype Ontology (HPO) (1) is widely used
for the annotation of human phenotypes and has been
employed in many biomedical applications aiming to
understand the phenotypic consequences of genomic
variation (2). Such applications include: linking human
diseases to animal models (3–5), inferring novel drug inter-
actions (6), prioritizing gene-disease targets (7, 8) and
describing rare clinical disorders (9).
Linking from the literature to conceptual systems like
HPO has been an ongoing endeavour within the text
mining community that attracted substantial interest,
e.g. (10–12), because of its potential for exploiting the data
from millions of existing patient reports, case studies or
controlled trials. This concept recognition (CR) task is
similar to other well-studied tasks such as gene or protein
name normalization, yet it is accompanied by its own set
of challenges. In general, the challenges associated with
this task are: (i) ambiguity, i.e. the same term may refer to
multiple different entities—e.g. ‘irregular ossification of
the proximal radial metaphysis’ vs. ‘radial club hand’—
radial refers to the anatomical entity radius in the former
case and the anatomical coordinate radial in the latter;
similarly ‘short long bones’ vs. ‘long metacarpals’—‘long’
acts as part of the name of an anatomical entity (the long
bones) in the former and represents a quality in the latter;
(ii) use of abbreviations—e.g. ‘segmentation defects in
L4-S1’; (iii) use of metaphorical expressions—e.g.
‘bell-shaped thorax’, ‘hitchhiker thumb’, ‘bone-in-bone
appearance’; (iv) use of hedging and various forms of
qualifiers—e.g. ‘subtle flattening and squaring of the meta-
carpal heads’, ‘segmentation defects appear to affect
L4-S1’; (v) complex intrinsic structure—the lexical struc-
ture of phenotype descriptions may take several forms.
They may have a canonical form, i.e. a conjunction of
well-defined quality-entity pairs, where entities represent,
e.g. an anatomical structure in focus (e.g. thorax) and qual-
ities denote certain characteristics of the entities (e.g.
bell-shaped)—resulting in the phenotype ‘bell-shaped
thorax’. On the other hand, they may also have a non-
canonical form, in which entities and qualities are
associated either via verbs (e.g. ‘Vertebral-segmentation
defects are most severe in the cervical and thoracic
regions’) or via conjunctions (e.g. ‘short and wide ribs with
metaphyseal cupping’). At the same time, each component
of a phenotype description may have a nested structure, as
in ‘flattening, underdevelopment and squaring of the heads
of the metacarpal bones, particularly at metacarpal IV
bilaterally’. All these challenges, and in particular the latter
three, makes the identification of the boundaries of pheno-
type descriptions particularly difficult.
To date there have only been a few controlled studies
focused on the automated annotation and/or harmonization
of phenotype concepts in the scientific literature (13–15).
Critically, none of these have used gold standard representa-
tions, hence making it hard to compare performance, e.g.
due to idiosyncrasies in the annotation method. Against this
background, our study has three goals:
• to introduce the first HPO-specific corpus—aimed to pro-
vide a reference standard for bootstrapping community
efforts in phenotype CR; by CR, we mean the identifica-
tion of entities of interest in free text and their resolution
to ontological concepts, as opposed to named entity rec-
ognition that focuses only on the first part.
• to provide a set of manually crafted test suites [adapted
from the original idea proposed by Cohen et al.
(16)]—aimed at covering a broader range of concept
types and to act as a standardized manner to perform
error analysis and
• to benchmark the landscape of existing phenotype CR
systems against both this gold standard as well as against
the proposed test suites.
Consequently, the contributions of this article include:
• a novel HPO annotated corpus consisting of 228
abstracts annotated by three experts, with a total of
1933 annotations (i.e. the text spans containing entities
of interest and their corresponding HPO concepts) and
covering 460 unique HPO concepts
• a set of 32 types of test suites comprising 2164 entries
and structured according to the 21 top-level HPO pheno-
typic abnormalities and
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• a comprehensive evaluation of three CR systems capable
of annotating HPO concepts: the NCBO Annotator (17),
the OBO Annotator (18) and the Bio-LarK CR (available
at http://bio-lark.org).
Materials and methods
Corpus construction
Our data set consists of a set of 228 abstracts cited by the
Online Mendelian Inheritance in Man (OMIM) database
(19). OMIM is a manually curated collection of human
hereditary disorders together with their suspected or
confirmed genetic origins. Each abstract was chosen for
its relevance to an OMIM human heritable disease.
The collection was compiled with the aim to match the
44 complex dysmorphology syndromes discussed in the
initial HPO study (20). These were originally selected from
the list of Pubmed citations provided by OMIM at ftp://
ftp.ncbi.nlm.nih.gov/repository/OMIM/pubmed_cited. All
abstracts associated with a disease have been curated.
Table 1 lists the distribution of the OMIM entries in the
corpus. The head of the distribution consists of a limited
number of neurodevelopmental and skeletal disorders
(e.g. Angelman syndrome, Branchiootorenal syndrome 1
or Brachydactyly type C), while the tail is comprised in
majority by skeletal dysplasias (e.g. Brachydactyly type
A2, Oculodentodigital dysplasia or Symphalangism C. S.
Lewis type).
The corpus has been annotated by a team of three
experts, or more concretely, by the creators of the HPO
(Prof. Peter Robinson, Dr. Sebastian Ko¨hler and Dr.
Sandra Do¨lken). The clinical validity of the annotations
has been ensured by two of the team members—i.e. Prof.
Peter Robinson and Dr. Sandra Do¨lken—both with exten-
sive clinical experience in human genetics. The actual
annotation process has been performed in a peer-to-peer
manner and consisted of two steps. Initially, two experts
conjointly annotated the corpus. This was followed by a
post-annotation validation phase, in which the third anno-
tator—paired up with one of the two initial annotators—
performed a consistency and completeness check.
Consistency has also been ensured via a set of annota-
tion guidelines that dictated the form of the phenotypic
concepts, their lexical boundaries and the process of han-
dling negation. These guidelines are:
1. Phenotype concepts should only be considered if they
are present in a canonical form—e.g. include ‘hypoplas-
tic nails’ or ‘nail hypoplasia’, but not ‘nails were
hypoplastic’.
2. Conjunctive terms are allowed—e.g. ‘synostosis of
some carpal and tarsal bones’.
3. Subject to the type of conjunction, atomic text spans are
to be annotated with the corresponding HPO concepts.
For example, the text span ‘synostosis of some carpal
and tarsal bones’ represents a conjunction of two pheno-
type concepts: HP: 0008368 (Synostosis involving tarsal
bones) and HP: 0009702 (Synostosis involving the
carpal bones). Since the qualifier is preceding the
anatomical conjunction, the entire text span should be
annotated with both HPO concepts. On the other
hand, when the qualifier is succeeding the anatomical
conjunction—i.e. a mirror of the previous case—the text
span should be split into the corresponding atomic
phenotypes. For example, ‘branchial arch, otic and renal
malformations’ results in three annotations:
• ‘branchial arch, otic and renal malformations’—HP:
0009794 (Branchial anomaly)
• ‘otic and renal malformations’—HP: 0000598
(Abnormality of the ear)
• ‘renal malformations’—HP: 0000792 (Abnormal
renal morphology)
4. Negated phenotypes should be included—i.e. the text
span ‘kidney anomalies’ in the context of ‘no kidney
anomalies were found’ should be annotated with HP:
0000077 (Abnormality of the kidney). Here, the
assumption was that negation can be dealt with at a
different level and via other means.
As a note to point 1 mentioned earlier, non-canonical
phenotypes have been excluded from the annotation
process for two reasons. First, such lexical constructs are
more likely to be present in clinical summaries or
Electronic Health Records (EHRs) than in scientific publi-
cations. In practice, the corpus contains just a few such ex-
amples. Second, we were aware that, with the exception
of Bio-LarK CR, the other CR systems are not able to han-
dle such phenotypes, and as such we would not have been
able to provide a fair basis for comparison.
Benchmarking phenotype CR systems
A wide variety of CR systems have been previously
described—most of which are aimed at a specific purpose
or domain. In this context, we focus on and benchmark
three annotation tools that are able to perform CR using
the HPO: the NCBO Annotator (17)—an ontology-agnos-
tic CR system, the OBO Annotator (18) and the Bio-LarK
CR—both of which have been built with HPO as a direct
target.
Other systems we might have applied include
ConceptMapper (21), Whatizit (22), Bio/MedLee (23),
Apache cTAKES (24), or the well-known MetaMap (25).
These systems were, however, either difficult to access or did
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not provide a route to use HPO as a desired annotation out-
come. The CR systems employed adopt a range of techniques
but tend to avoid deep parsing and make use of a range of
shallow parsing (e.g. for named entity recognition and part of
speech tagging) and pattern-based techniques, supplemented
with restrictions and inferences on HPO. In all cases, we have
treated the systems as black boxes (i.e. off-the-shelf solutions)
and hence we have no access to any degree of confidence they
may have in their concept selections.
M1: NCBO Annotator. The NCBO Annotator is a CR sys-
tem available online and as well as part of the NCBO vir-
tual appliance. It identifies and indexes biomedical
concepts in unstructured text by exploiting a range of over
300 ontologies stored in BioPortal (26)—the largest reposi-
tory of biomedical ontologies. The system can be applied
to all ontologies or restricted to a specified set—such as in
our case, the HPO.
NCBO Annotator operates in two stages: CR and,
optionally, semantic expansion. CR performs lexical
matching by pooling terms and their synonyms from across
the ontologies and then identifies lexical variants in free
text and assigns annotations using Mgrep (27). Mgrep
applies stemming as well as permutations of the word
order combined with a radix-tree-search algorithm to
allow for the identification of the best matches of diction-
ary entries to a particular text span. During semantic
expansion, various rules such as transitive closure and
semantic mapping using the Unified Medical Language
System (UMLS) Metathesaurus are used to suggest related
Table 1. Distribution of disorders associated with the the HPO
gold standard corpus
Disorder (OMIM) Count
Angelman syndrome (OMIM:105830) 56
Neurofibromatosis type II (OMIM:101000) 46
Basal cell nevus syndrome (OMIM:109400) 40
Branchiootorenal syndrome 1 (OMIM:113650) 27
Brachydactyly type C (OMIM:113100) 14
Branchiooculofacial syndrome (OMIM:113620) 13
Townes-Brocks syndrome (OMIM:107480) 11
Arthrogryposis distal type 1 (OMIM:108120) 9
Brachydactyly type A1 (OMIM:112500) 7
Popliteal pterygium syndrome (OMIM:119500) 6
Prader-Willi syndrome (OMIM:176270) 5
Arthrogryposis distal type 2B (OMIM:601680) 4
Van der Woude syndrome (OMIM:119300) 3
Neurofibromatosis type I (OMIM:162200) 3
Arthrogryposis distal type 2A (OMIM:193700) 3
Arthrogryposis distal type 5 (OMIM:108145) 2
Gordon syndrome (OMIM:114300) 2
Trismus-pseudocamptodactyly syndrome
(OMIM:158300)
2
Schwannomatosis (OMIM:162091) 2
Neurofilament protein heavy polypeptide
(OMIM:162230)
2
Hemifacial microsomia (OMIM:164210) 2
Symphalangism proximal cushing symphalangism
(OMIM:185800)
2
Branchiootic syndrome 1 (OMIM:602588) 2
Arthrogryposis distal type 4 (OMIM:609128) 2
Acrodysostosis 1 with or without hormone resist-
ance (OMIM:101800)
1
Arthrogryposis-like hand anomaly and sensorineural
deafness (OMIM:108200)
1
Stickler syndrome type I (OMIM:108300) 1
Brachydactyly type A2 (OMIM:112600) 1
Charcot-Marie-Tooth disease demyelinating type 1B
(OMIM:118200)
1
Arthrogryposis distal type 9 (OMIM:121050) 1
Arthrogryposis distal type 2E (OMIM:121070) 1
Crouzon syndrome (OMIM:123500) 1
Duane retraction syndrome 1 (OMIM:126800) 1
Multiple endocrine neoplasia type I
(OMIM:131100)
1
Treacher Collins-Franceschetti syndrome
(OMIM:154500)
1
Mesothelioma malignant (OMIM:156240) 1
Neurofibromatosis familial spinal (OMIM:162210) 1
Neurofibromatosis type III mixed central and per-
ipheral (OMIM:162260)
1
Noonan syndrome 1 (OMIM:163950) 1
Oculodentodigital dysplasia (OMIM:164200) 1
Polydactyly postaxial type A1 (OMIM:174200) 1
Greig cephalopolysyndactyly syndrome
(OMIM:175700)
1
(continued)
Table 1. Continued
Disorder (OMIM) Count
Hutchinson-Gilford progeria syndrome
(OMIM:176670)
1
Multiple pterygium syndrome autosomal dominant
(OMIM:178110)
1
Symphalangism C. S. Lewis type (OMIM:185650) 1
Thumbs stiff with brachydactyly type A1 and devel-
opmental delay (OMIM:188201)
1
Waardenburg syndrome type 1 (OMIM:193500) 1
Williams-Beuren syndrome (OMIM:194050) 1
Diarrhea 1 secretory chloride congenital
(OMIM:214700)
1
Cystic fibrosis (OMIM:219700) 1
Hydrocephalus autosomal dominant
(OMIM:600256)
1
Bor-Duane hydrocephalus contiguous gene syn-
drome (OMIM:600257)
1
Cholesteatoma congenital (OMIM:604183) 1
Basal cell carcinoma susceptibility to 1
(OMIM:605462)
1
The listing includes the name of the OMIM disease and the number of
abstracts associated with it (the Count column).
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concepts from within and across ontologies based on
extant relationships. For the purpose of our experiments,
only the CR part is relevant.
M2: OBO Annotator. OBO Annotator (18) was designed
to perform phenotype recognition of rare diseases specifi-
cally relating to patient case reports. Their method involves
identifying a set of seed linguistic patterns from case
reports in PubMed abstracts in a controlled search using
cerebrotendinous xanthomatosis as the motivating topic.
OBO Annotator proceeds through each sentence trying to
exactly match each string within the seed pattern to HPO
concepts using a longest match assumption. If no longest
match can be found the candidate string is divided into
shorter parts and matching is tried again, e.g. in the case of
coordinated terms such as ‘brain and cerebellar atrophy’.
Orthography, tokenization, stemming, punctuation and
stop words are all handled within the system. OBO
Annotator supports contextual variations using transitive
closure on the concepts in the HPO hierarchy, i.e. to infer
term similarity based on ancestors and descendants of each
concept under consideration. More specific annotations
are preferred over more general ones where there are over-
lapping annotations.
M3: Bio-LarK CR. The Bio-LarK concept recognizer has
been developed as part of the SKELETOME project (28),
with an initial goal of performing automatic annotation of
skeletal phenotypes in patient clinical summaries.
Subsequently, it was extended to enable phenotype CR
using HPO. Bio-LarK CR uses an Information Retrieval
approach to index and retrieve HPO concepts, combined
with a series of language techniques to enable term normal-
ization and decomposition (e.g. token lexical variation).
In addition to standard CR, the system is able to decom-
pose and align conjunctive terms (e.g. ‘short and broad
fingers’ aligned to HP: 0009381—Short fingers and HP:
0001500—Broad fingers), as well as recognize and process
non-canonical phenotypes, such as ‘fingers are short and
broad’—which would be aligned to the same terms as in
the previous example. This is realized via an efficient
pattern matching approach that uses manually crafted
rules over the shallow structure of the sentence. The recog-
nition of non-canonical phenotypes is an optional feature
of Bio-LarK CR and can be enabled or disabled subject to
the intented use of the system.
Experimental setup
The HPO gold standard corpus was used to assess the CR
performance of the three above-listed systems. More con-
cretely, the systems have been applied on the free text of the
228 abstracts, which resulted in an individual set of
annotations. These annotations have then been aligned to
the gold standard annotations using exact boundary match-
ing. It is worth mentioning that exact boundary detection
represents the default strategy for all chosen systems.
Furthermore, the annotation guidelines (see earlier) explic-
itly impose the fine-grained decomposition of coordinations,
hence overlap matching strategies are not required.
Standard evaluation metrics have been computed on the
alignment results:
• Precision (P); P¼TP/(TPþ FP)
• Recall (R); R¼TP/(TPþ FN)
• F-Score—the harmonic mean of Precision and Recall;
F-Score¼ 2*PR/ (PþR)
In the equations earlier, TP is the number of true posi-
tive annotations (i.e. the HPO concepts suggested by the
system match those listed in the gold standard); FP is the
number of false positive annotations (i.e. the HPO con-
cepts suggested by the system do not match those listed in
the gold standard); and FN is the number of false negative
annotations (i.e. the number of text spans failed to be iden-
tified by the system).
Towards standardized error analysis: Introducing the
HPO test suite package
The experimental setup described earlier provides a clear
view on the systems’ CR performance on real data.
However, since the coverage of the HPO terms is not
exhaustive, it is not able to create a comprehensive picture
of the systems’ strengths and weaknesses. Furthermore, as
in the case of any other gold standard evaluation, error
analysis is qualitative, the process of interpreting and dis-
cussing the errors being subject to the observations made
by the evaluator.
Cohen et al. (16) have adopted the test suite methodol-
ogy from software engineering and proposed a stratified
approach to data sampling based on several criteria. Each
criterion focuses on a set of concepts that share a particular
property, such as length in tokens, presence of punctuation,
coordination, etc. This leads to a framework able to charac-
terize the strengths of the linguistic patterns used within
each CR system and, moreover, to a platform that can be
applied and shared to perform standardized error analysis.
Hence, as a second major contribution, following
the work done by Cohen et al., we propose and make
available a set of 32 manually crafted criteria (or test
cases) comprising 2164 entries. Each test case entry
corresponds to the label of an HPO concept and was
manually selected to conform with the corresponding test
case. Furthermore, since the linguistic characteristics of
phenotypes depend, to some extent, on the anatomical
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localization of the abnormality, we have structured these
test suites according to the 21 top-level HPO phenotypic
abnormalities.
Figure 1 depicts the distribution of 32 test cases
(or criteria) according to their types (their complete
description is available in Section S2 in the Supplementary
Material) and with respect to the 21 top-level HPO pheno-
typic abnormalities. On average, each criterion has 70 test
case entries. The test cases can be grouped into the follow-
ing categories (examples are provided in the same table):
• Length-based tests—characterize the system’s ability to
cater for the wide variety of concept label length in
tokens. The length of all HPO concept labels ranges
from 1 to max. 14.
• Tests accounting for the presence of certain types of tokens,
including punctuation, isolated numerals (Arabic or
Roman) and stop words (IN, OF, TO, BY, FROM, WITH)
• Lexical variation tests covering the transformation of
some of the tokens from singular to plural or from nouns
to adjectives and vice versa
• Token ordering tests—opposing canonical and trans-
formed canonical ordering
• Synonym tests—original concept labels are replaced by
suitable synonyms listed in the ontology
• Other, more specialized tests, such as non-English canon-
ical, i.e. the ability to detect non-English tokens, meta-
phoric constructs—phenotypes are perhaps the only
domain-specific concepts that contain metaphoric
expressions, e.g. bone-in-bone appearance and coor-
dination—composite terms created via conjunctions of
several atomic HPO concepts.
Figure 1 also depicts the distribution of the test cases
according to the top-level HPO categories, which follows to
a large extent the natural distribution of concepts in the
HPO (as shown in Section S3 in the Supplementary
Material). On average, each such HPO category has 100
test case entries. The actual number of entries depends on
the distribution and diversity of the types of concept labels
in the respective category. For example, ‘Abnormality of the
voice’ and ‘Abnormality of the breast’ have the lowest cov-
erage in HPO, and hence, also have the lowest number of
test case entries assigned. On the other hand, ‘Abnormality
of the cardiovascular system’ and ‘Abnormality of the integ-
ument’ have a wider variety of terms (from a lexical and
morphological perspective) and hence they are better repre-
sented in terms of test cases, each with more than 150
entries. Finally, while ‘Abnormality of the skeletal system’ is
by far the most dominant category in terms of coverage—
almost 30% of HPO terms are under this category—this
does not translate proportionally in the number of test case
entries. Skeletal abnormalities have a fairly uniform lexical
representation and consist of a large number of repetitions
and partonomies of anatomical localizations, leading to a
low lexical and morphological variety.
The test suite experimental setup was similar to the gold
standard approach. We have treated each test case as an
individual free text document and used them as input for
the CR systems. The alignment strategy and evaluation
metrics were the same as earlier, i.e. exact boundary match-
ing with Precision, Recall and F-Score. The use of exact
boundary matching in this context has the role to penalize
systems that produce also concepts nested within the
provided label, in addition to the concept representing the
target of the test case entry. Furthemore, this is also required
to enable an appropriate processing of term coordination.
Results
HPO gold standard corpus
The resulting corpus comprises 1933 individual annotations
(with an average length of 2.42 tokens or words), which
map to 460 unique concepts in HPO (4.4% coverage). In
total, the annotations are related to 77 OMIM disorders.
In order to create a better overview of the concepts
captured in the corpus, we have mapped them to the 21
top-level phenotype abnormalities defined by HPO.
Figure 2 depicts the distribution of the resulting annota-
tions according to these categories, when looking at both
the overall percentage (i.e. counting every instance of a
particular annotation—e.g. if ‘meningioma’ appears three
times in an abstract, the resulting count would be three), as
well as the unique coverage (i.e. counting the unique
instances of each concept—using the same example, if
‘meningioma’ appears three times in an abstract, the result-
ing count would be one). From an overall perspective, the
most highly represented concepts include abnormalities of
the nervous system (30.36%), neoplasms (22.50%), abnor-
malities of the integument (16.6%) and abnormalities of
the skeletal system (15.62%). From a unique coverage per-
spective, the distribution is slightly different, with abnor-
malities of the skeletal system, abnormalities of the
nervous system and abnormalities of the head and neck
dominating the corpus—25.86%, 22.82% and 14.78%,
respectively. The two distributions mirror fairly closely the
natural distribution of HPO concepts in the ontology (see
Section S3 in the Supplementary Material).
Experimental results
The evaluation results on the HPO gold standard corpus
(HPO GS) are presented in Table 2, while a more detailed
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overview according to the top-level HPO categories is
depicted in Figure 3. The OBO Annotator and Bio-LarK
CR share the best performance—0.54 and 0.56 F-Score.
While the overall F-Score shows minor differences, we can
observe that the OBO Annotator focuses more on precision
(0.69 as opposed to 0.65 of Bio-LarK) and Bio-LarK CR
more on recall (0.49 as opposed to 0.44 of the OBO
Annotator). The Recall of the NCBO Annotator was simi-
lar to that of the OBO Annotator—with a slight decrease
of 0.05—however, the Precision, and hence the overall
F-Score, was substantially lower: 0.54 Precision (on aver-
age 0.13 less the other two systems), leading to 0.45
F-Score (0.09 lower than OBO Annotator and 0.11 lower
than Bio-LarK CR).
Although the HPO GS evaluation has shown relatively
consistent performance across all three tools, the overall
results on the test suite evaluation were remarkably differ-
ent—as listed in Table 3 (Figure 4 depicts an in-depth per-
spective according to each test case). Here, Bio-LarK CR
outperformed both NCBO Annotator and OBO
Annotator, achieving 0.97 Precision and an overall 0.95 F-
Score. Surprisingly, the OBO Annotator, which performed
on par with Bio-LarK on the gold standard, had the lowest
Precision (0.54) and a very low Recall of 0.26, leading to
Figure 1. Distribution of HPO test cases according to their types mapped to the top-level HPO categories. The larger the symbol, the more test case
entries the corresponding mapping has. For example, the largest number of test case entries of Length-1 is present in Abnormality of the integument.
In addition to providing an overview on the test suite content, this figure also depicts a birds-eye view over the variation in terms of characteristics of
the concept lexical representations in the different top-level HPO categories. We can observe, e.g. that only a very few top-level categories contain
concept labels with a length greater than 10. Similarly, metaphoric constructs seem to be present only in skeletal abnormalities, which also dominate
together with the abnormalities of the integument and of the metabolism the range of labels containing punctuation.
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0.35 F-Score. Moreover, the NCBO Annotator achieved
remarkable results in comparison to its performance on the
HPO GS, with a 0.95 Precision (very similar to Bio-
LarK)—i.e. an increase of 0.41 when compared to the
HPO GS results, and a Recall of 0.84—0.09 lower than
Bio-LarK, however, 0.45 higher than its Recall on HPO
GS. Whilst the results of the two experiments are not
directly comparable, they can be used to provide a comple-
mentary understanding of the system performance, given
that one has been performed on a real-world corpus, and
the other on a controlled test suite.
Discussion
Distribution of concepts in the HPO GS corpus
As mentioned earlier, Figure 2 depicts the distribution of
the concept annotations according to the top-level HPO
categories both from the overall as well as from the unique
perspectives. It is important to remark that the interpreta-
tion of these distributions should take into account two
inter-weaved aspects. First, the Overall distribution quanti-
fies the amount of duplicate annotations in comparison to
unique annotations—or more concretely the comparison
between counting a particular concept annotation every
time it appears against counting it only once. For example,
we can observe that neoplastic, neural and integumental
anomalies contain a large number of duplicate
annotations—visible in the change of level from Overall to
Unique. This leads to them covering only a fraction of the
Figure 2. Distribution of HPO annotations according to the top-level HPO categories. Two distributions are shown: an overall distribution that
accounts for duplicate concept annotations (i.e. every instance of an annotation is counted), and a unique distribution that shows the counts of the
unique concept annotations (i.e. every concept is counted a single time, indifferently of how many annotations exist in the corpus).
Table 2. System performance on the HPO corpus using exact
matching and concept identification
Precision Recall F1
NCBO Annotator 0.54 0.39 0.45
OBO Annotator 0.69 0.44 0.54
Bio-LarK CR 0.65 0.49 0.56
OBO Annotator and Bio-LarK CR have a similar overall efficiency, the
difference in F-Score being of only 0.02. The efficiency of the NCBO
Annotator was on average with 10 percentage points lower than of the other
two systems.
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existing set of HPO concepts in the corresponding top-level
category, while annotations of skeletal abnormalities,
e.g. are in most cases unique. Second, both distributions
capture the intrinsic multi-inheritance nature of the pheno-
types in HPO—i.e. the fact that a phenotype concept may
have ancestors leading to several different top-level catego-
ries. To be more precise, 19.12% of the set of unique con-
cepts have more than one parent. For example, HP:
0000250 (Dense calvaria) is both an Abnormality of the
skeletal system (via HP: 0002683—Abnormality of the
calvaria) as well as an Abnormality of the head and neck
(via HP: 0004330—Increased skull ossification). Hence,
while from a unique counting perspective annotations of
skeletal abnormalities are dominant, in practice, they are
shared with other categories, such as abornormalities of
the nervous system. In conclusion, the corpus focuses on a
set of cohensive and tightly coupled abnormalities of the
skeletal (including head and neck), integument and nerv-
ous systems with relations to neoplasm.
Error analysis
The systems’ overall performance on the gold standard to
some extent matched our expectations. Phenotype con-
cepts are highly complex, in particular due to their intrinsic
lexical structure, as well as due to their structural and
semantic ambiguity—the reported performance reflects
this complexity.
In order to provide a finer-grained view on this per-
formance, Figure 3 depicts the F-Score achieved by the
Figure 3. F-Score results achieved by the three systems on the HPO gold standard, distributed according to the HPO top-level category.
Table 3. System performance on the HPO test suites using
exact matching and concept identification
Precision Recall F1
NCBO Annotator 0.95 0.84 0.89
OBO Annotator 0.54 0.26 0.35
Bio-LarK CR 0.97 0.93 0.95
As opposed to the results listed in Table 2, the NCBO Annotator achieved
an overall F-Score similar to the one of Bio-LarK CR—i.e. 0.89 compared to
0.95. Surprisingly, the OBO Annotator’s efficiency was much lower than of
the other two systems (F1 of 0.35), although on real data it performed on par
with Bio-LarK CR.
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systems according to the top-level HPO category. First,
we can observe that three HPO top-level categories are
not present in the CR results—i.e. ‘Abnormality of
blood and blood-forming tissues’, ‘Abnormality of the
breast’ and ‘Abnormality of the voice’—whilst the two
others have poor F-Score results—i.e. Abnormality of
immune system and of metabolism/homeostasis. These
results are, however, more likely due to their very poor
representation in the HPO GS. On the other hand, the
systems performed better on some other poorly repre-
sented categories, such as ‘Growth abnormality’,
‘Abnormality of the respiratory system’ or ‘Abnormality
of prenatal development or birth’.
Second, we can use this overview as an indication of
the systems’ strengths and weaknesses in recognition of
certain types of HPO concepts. For example, Bio-LarK
outperformed the other systems on ‘Abnormality of
the abdomen’,’Abnormality of the connective tissue’ and
‘Neoplasm’, the OBO Annotator on ‘Abnormality of the
genitourinary system’ and ‘Abnormality of the nervous sys-
tem’, while the NCBO Annotator on ‘Growth
abnormality’ and ‘Abnormality of the cardiovascular sys-
tem’. No system consistently outperformed the others on
all categories.
A closer inspection of the errors in the CR process
reveals three particular types:
• Coordination—e.g. ‘aplastic or hypoplastic nails’—the
OBO Annotator and Bio-LarK were able to correctly
identify and decompose only some examples of coordi-
nation. In particular, the OBO Annotator was unable to
decompose most coordinations created using the con-
junctive connector ‘OR’. The NCBO Annotator identi-
fied only the tail units within a coordination (i.e.
‘hypoplastic nails’), without being able to correctly iden-
tify any entire coordination.
• Canonical order transformed—e.g. ‘Brachydactyly type
A1’ instead of ‘Type A1 brachydactyly’ (HP: 0009371).
Both the OBO Annotator and the NCBO Annotator
were unable to correctly identify concepts that had their
canonical order transformed in the text.
• Acronyms and complex concept conjunctions—e.g.
‘BDA1’ (standing for ‘Type A1 brachydactyly’) or ‘ster-
eotyped jerky movements’—which is a conjunction of
HP: 0000733 (Stereotypical motor behaviours) and HP:
0007087 (Involuntary jerking movements). No system
was able to identify such concepts: (i) acronyms—
because none of the systems performs acronym expan-
sion and these were not listed as synonyms in the concept
definition; (ii) complex conjunctions—these require
human interpretation in order to correctly align the cor-
responding underlying concepts.
The above listed errors types are partly confirmed also
by the test suite evaluation. Figure 4 depicts the F-Score
results according to the test criteria. For example, the pair
{Canonical ordering—Canonical ordering—transformed}
should present mirrored results if a system is able to cater
for lexical groundings that do not respect the token order as
defined in the concept label (i.e. mapping ‘Hypoplasia of the
optic nerve’ to ‘Optic nerve hypoplasia’). Here, we can see
an important decrease in F-Score for the NCBO Annotator
and only a slight decrease for Bio-LarK, which confirms the
finding earlier. The OBO Annotator, has however an unex-
pected behaviour, reporting an increase in F-Score in this
category. When inspecting the actual concepts, we were not
able to find a correlation between the concept correctly
identified in the canonical ordering and those in the canoni-
cal ordering transformed. More concretely, in most cases
the system has identified one, but not the other, with a slight
preference for the canonical ordering transformed.
The results in the Canonical ordering pair can be corre-
lated with those in the Lexical variation category and in
the {Singular—Plural} test pair (designed in the same man-
ner as the Canonical ordering pair). Lexical variation refers
to altering the lexical form of some of the tokens without
altering the overall semantics—e.g. from ‘Hypoplasia of
the optic nerve’ to ‘Hypoplastic optic nerve’. It is impor-
tant to note that there are cases in which transforming the
canonical ordering requires a certain degree of lexical var-
iation. Here, only Bio-LarK is able to perform consis-
tently—achieving high F-Scores (over 0.75). The NCBO
Annotator has difficulties, in particular, in dealing with the
lexical variation—as opposed to the OBO Annotator,
which achieves an F-Score of 0.25. The same counterbal-
anced results are visible also on the {Singular—Plural} test
case where the NCBO Annotator displays a 0.2 decrease in
F-Score from singular to plural, while the OBO Annotator
decreases from 0.8 F-Score on plural to 0.3 on singular—
hence showing a clear preference for plural terms. Finally,
the Coordination test case mirrors the gold standard
results, with Bio-LarK and the OBO Annotator outper-
forming the NCBO Annotator.
An overall summary of lessons learned from the test
suite evaluations is listed later:
• NCBO Annotator performs best when the text spans of
interest map perfectly to the lexical groundings of the
associated concepts—indifferently of the length of
these lexical groundings or their internal composition
(i.e. punctuation or stop words)
• The OBO Annotator is able to handle better lexical var-
iation and coordination, but encounters major issues
when targeting lexical groundings with higher number of
tokens or those consisting of arabic numerals.
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• Bio-LarK performs fairly consistently across all tests,
with some difficulties with coordination and lexical
variation.
Section S4 in the Supplementary Material provides
additional insight into the systems’ performance on test
suites, by looking at an orthogonal dimension—i.e. evalua-
tion results according to the HPO top-level category.
It is notable that the distribution of the HPO gold
standard phenotypes mirrors the categories of disorders
included in the corpus—i.e. neurodevelopmental and skele-
tal disorders—although they also mirror to a large extent
the natural distribution of phenotypes in HPO (as shown
in Section S3 in the Supplementary Material). This may
influence the global preception ofthe CR efficiency of a
particular system. Hence, the system CR results discussed
earlier should be stricly interpreted in the context provided
by the corpus annotations and the possible bias towards
abnormalities of the integument and of the nervous and
skeletal systems (including head and neck).
Alternatively, this bias may prove the utility of the test
suite corpora and offer the explanation for the large dis-
crepancy in CR efficiency shown by the OBO Annotator
on the gold standard vs. the test suite. More concretely, the
OBO Annotator seems to cater well for this particular dis-
tribution of phenotypes, but cannot handle the wider
range—in terms of constructs and lexical variety—
captured by the test suites. Oppositely, the consistent
behaviour exhibited by the NCBO Annotator and Bio-
LarK CR on both corpora leads to the conclusion that they
have a higher chance of achieving the same results on a
new corpus—perhaps built using the same underlying for-
mat (i.e. publication abstracts).
The goal and utility of the test suite corpus
The goal of the test suites introduced in this article is to
provide a standardized benchmarking environment for
error analysis—one that enables us, and others, to lay out
a quantitative perspective on a set of errors a CR system
may produce. Ideally, these should be a mixture of ‘stand-
ard’ cases (i.e. cases one would expect a system to handle
correctly—similarly to paradigm employed in software
engineering) and ‘challenging’ cases. And while we have
tried to include some of the latter (e.g. the canonical order
transformed or the term coordination)—the vast majority
of our test cases fit into the former category. As a side
remark, research on building challenging test cases in the
CR context is almost inexistent. And whilst this idea has
been raised, there is a paucity of published research in the
area, and only lately it has started to gain some attention,
in particular with the goal of building such test cases auto-
matically (29).
By providing an evaluation both on real data, as well as
on structured test cases, our intention is to describe two
dimensions of the same story—dimensions that are com-
plementary but not necessarily nested within each other.
The results on the real data reflect the systems’ efficiency
in the context of the concept distributions and characteris-
tics underpinning this data. The real data covers aspects
absent from the test cases and found, in their majority, in
the qualitative error analysis accompanying the corre-
sponding evaluation—e.g. lack of synonyms, lack of acro-
nym expansion, particular forms of term coordination.
The structured test cases, on the other hand—as mentioned
earlier—depict a ‘what-if’ type of analysis—i.e. ‘what
would be the behaviour of system X if the real data would
Figure 4. F-Score results achieved by the three systems on the HPO test suites, distributed according to the type of the test case.
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contain a concept found in the Y test category?’ And we
believe that this goal has been attained—even if more
emphasis should be placed on challenging test cases. For
example, the test suites show that some systems encounter
difficulties in handling concepts with long lexical
groundings—e.g. the OBO Annotator efficiency is inexis-
tent for lengths greater than nine. Such a finding would not
be possible with the real data, where the concepts’ average
length in tokens is 2.42. Similarly, the same test suites
show that the NCBO Annotator is not able to handle coor-
dination and transformed canonical ordering, which again,
is covered only in part by the real data.
In conclusion, the two dimensions require a tighter
integration, in order to enable a correlation of the experi-
mental results emerging from them. We intend to work on
this aspect in the near future, in parallel to supporting the
progress of the research on CR test suites.
Conclusions and future work
Phenotype recognition is essential for interpreting the evi-
dence about human diseases in clinical records and the
scientific literature. In this article, we have presented the
first corpus of manually annotated abstracts using the HPO.
The corpus represents a valuable resource for gaining
a deeper understanding of the linguistic characteristics of
phenotypes both from an overall perspective, and with
respect to their classification according to the HPO top-level
categories.
Furthermore, inspired by the work of Cohen et al. (16),
we have provided a set of 32 manually crafted HPO-based
test suites. The discussion presented on the experimental
results shows the utility and added-value of CR test suites.
First, they provide a controlled environment for detecting
patterns of errors emerging from the CR process.
Identifying such patterns is beneficial for both the users of
the system—as they understand the systems’ strengths and
weaknesses—as well as for the systems’ developers—as
they are able to focus their attention on correcting those
aspects associated with the low-performing test suites.
Second, test suites enable reproducibility, standardized
error analysis and a fair ground for comparing system
performance.
Finally, we evaluated three off-the-shelf CR systems
that are able to identify HPO concepts. These have been
benchmarked using both the gold standard and the test
suite corpora.
Future work will focus on expanding the gold standard
corpus to increase the coverage of HPO concepts and on
designing additional test suites. In addition, we intend to
investigate the opportunity of devising hybrid CR system
configurations (or ensemble learners) that are able to take
advantange the strengths and weaknesses of the individual
systems, as detected by the test suites presented in this article.
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